Atherosclerotic vascular disease in systemic lupus erythematosus and related disorders

被引：0

作者：

La Rosa, J. C. ^{[1
]}

机构：

[1] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA

来源：

LUPUS | 2006年 / 15卷 / 11期

关键词：

atherosclerosis; lupus; risk factors; hyperlipidemia; inflammation;

D O I：

10.1177/0961203306071676

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atherosclerosis is a common cause of death and disability, even in premenopausal women, in systemic lupus erythematosus. The additional risk in SLE (and other related disorders) cannot be explained by levels of "classic" risk factors. There is evidence that SLE itself, its effects on atherosclerosis risk factors and the effect of the drugs used to threat SLE may all play a role in accelerating atherosclerosis in SLE. Even though "classic" risk factors do not explain all of the vascular risk in SLE, it is still vitally important that they be vigorously treated.

引用

页码：35 / 38

页数：4

共 23 条

[1]

[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]

[2] Premature coronary-artery atherosclerosis in systemic lupus erythematosus [J].

Asanuma, Y ;

Oeser, A ;

Shintani, AK ;

Turner, E ;

Olsen, N ;

Fazio, S ;

Linton, MF ;

Raggi, P ;

Stein, CM .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) :2407-2415

[3] Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].

Cervera, R ;

Piette, JC ;

Font, J ;

Khamashta, MA ;

Cervera, R ;

Piette, JC ;

Font, J ;

Khamashta, MA ;

Shoenfeld, Y ;

Camps, MT ;

Jacobsen, S ;

Lakos, G ;

Tincani, A ;

Kontopoulou-Griva, I ;

Galeazzi, M ;

Meroni, PL ;

Derksen, RHWM ;

de Groot, PG ;

Gromnica-Ihle, E ;

Baleva, M ;

Mosca, M ;

Bombardieri, S ;

Houssiau, F ;

Gris, JC ;

Quéré, I ;

Hachulla, E ;

Vasconcelos, C ;

Roch, B ;

Fernández-Nebro, A ;

Boffa, MC ;

Hughes, GRV ;

Ingelmo, M .

ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027

[4] Primary renal disease as a cardiovascular risk factor [J].

Crook, ED ;

Flack, JM ;

Salem, M ;

Salahudeen, AK ;

Hall, J .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 324 (03) :138-145

[5] European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts) [J].

De Backer, G ;

Ambrosioni, E ;

Borch-Johnsen, K ;

Brotons, C ;

Cifkova, R ;

Dallongeville, J ;

Ebrahim, S ;

Faergeman, O ;

Graham, I ;

Mancia, G ;

Cats, VM ;

Orth-Gomér, K ;

Perk, J ;

Pyörälä, I ;

Rodicio, JL ;

Sans, S ;

Sansoy, V ;

Sechtem, U ;

Silber, S ;

Thomsen, T ;

Wood, D .

ATHEROSCLEROSIS, 2003, 171 (01) :145-155

[6] DYSLIPIDEMIA AND ISCHEMIC-HEART-DISEASE MORTALITY AMONG MEN AND WOMEN WITH DIABETES [J].

GOLDSCHMID, MG ;

BARRETTCONNOR, E ;

EDELSTEIN, SL ;

WINGARD, DL ;

COHN, BA ;

HERMAN, WH .

CIRCULATION, 1994, 89 (03) :991-997

[7] Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction? [J].

Jungner, I ;

Sniderman, AD ;

Furberg, C ;

Aastveit, AH ;

Holme, I ;

Walldius, G .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (07) :943-946

[8] Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus [J].

Lee, AB ;

Godfrey, T ;

Rowley, KG ;

Karschimkus, CS ;

Dragicevic, G ;

Romas, E ;

Clemens, L ;

Wilson, AM ;

Nikpour, M ;

Prior, DL ;

Best, JD ;

Jenkins, AJ .

INTERNAL MEDICINE JOURNAL, 2006, 36 (04) :237-243

[9]

LEONG KH, 1994, J RHEUMATOL, V21, P1264

[10]

Lima DSN, 2002, J RHEUMATOL, V29, P292

← 1 2 3 →